Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Rheumatology|January 17, 2013
The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritisPaul Bird, Hedley Griffiths, Kathleen Tymms, et al.
Public Health in Practice (Oxford, England)|January 22, 2026
Antibiotic knowledge among ethnic minority groups in high-income countries: A mixed-methods systematic reviewLuisa Silva, Mayuri Gogoi, Zainab Lal, et al.
Clinical and Experimental Rheumatology|May 17, 2024
Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL datasetSabina Ciciriello, Geoffrey O Littlejohn, Tamas Treuer, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 26, 2018
Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and SafetyPaul Bird, William Bensen, Bassel El-Zorkany, et al.
The Journal of Rheumatology|April 5, 2007
Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritisFiona McQueen, Marissa Lassere, Paul Bird, et al.
The Journal of Rheumatology|September 3, 2015
The Longitudinal Reliability and Responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS)Ida K Haugen, Iris Eshed, Frederique Gandjbakhch, et al.
Annals of the Rheumatic Diseases|January 22, 2016
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)Christopher J Edwards, Francisco J Blanco, Jeffrey Crowley, et al.
International Journal of Rheumatic Diseases|October 30, 2013
A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease controlGeoffrey Littlejohn, Lynden Roberts, Mark Arnold, et al.
Pageof 13